XML 46 R36.htm IDEA: XBRL DOCUMENT
v3.23.2

FAIR VALUE MEASUREMENTS (Tables) | 6 Months Ended
--- | ---
Jun. 30, 2023
Fair Value Disclosures [Abstract] |
Schedule of Liabilities Measured on Recurring Basis | The following table presents our assets and liabilities measured at fair value on a recurring basis at June 30, 2023:
|  |  | Fair Value Measurements at
|  |  | June 30, 2023
| Total |  | Quoted Prices in Active Markets (Level 1) |  | Significant Other Observable Inputs (Level 2) |  | Significant Unobservable Inputs (Level 3)
Assets: |  |  |  |  |  |  |
ABTC restricted common shares | $ | 7,100,000 |  |  | $ | — |  |  | $ | 7,100,000 |  |  | $ | — |
Liabilities: |  |  |  |  |  |  |
Ionic convertible debenture derivative | $ | (600,000) |  |  | $ | — |  |  | $ | — |  |  | $ | (600,000) |
LINICO related derivative | (3,278,162) |  |  | — |  |  | (3,278,162) |  |  | — |
Haywood derivative | (605,000) |  |  | — |  |  | (605,000) |  |  | — |
GenMat derivative | (3,303,172) |  |  | — |  |  | (3,303,172) |  |  | — |
Total liabilities measured at fair value | $ | (7,786,334) |  |  | $ | — |  |  | $ | (7,186,334) |  |  | $ | (600,000) |
The following table presents our liabilities at December 31, 2022, measured at fair value on a recurring basis:
|  |  | Fair Value Measurements at
|  |  | December 31, 2022
| Total |  | Quoted Prices in Active Markets (Level 1) |  | Significant Other Observable Inputs (Level 2) |  | Significant Unobservable Inputs (Level 3)
Liabilities: |  |  |  |  |  |  |
Ionic convertible debenture derivative | $ | (420,000) |  |  | $ | — |  |  | $ | — |  |  | $ | (420,000) |
LINICO related derivative | (6,053,162) |  |  | — |  |  | (6,053,162) |  |  | — |
Haywood derivative | (1,480,000) |  |  | — |  |  | (1,480,000) |  |  | — |
GenMat derivative | (6,592,638) |  |  | — |  |  | (6,592,638) |  |  | — |
Total liabilities measured at fair value | $ | (14,545,800) |  |  | $ | — |  |  | $ | (14,125,800) |  |  | $ | (420,000) |

X
- Definition Tabular disclosure of the fair value of financial instruments, including financial assets and financial liabilities, and the measurements of those instruments, assets, and liabilities. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Name Accounting Standards Codification -Topic 820 -SubTopic 10 -Section 50 -Paragraph 2 -Subparagraph (a) -Publisher FASB -URI https://asc.fasb.org//1943274/2147482106/820-10-50-2 Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef -Name Accounting Standards Codification -Topic 825 -SubTopic 10 -Section 50 -Paragraph 11 -Publisher FASB -URI https://asc.fasb.org//1943274/2147482907/825-10-50-11 + Details
Name: | us-gaap_FairValueByBalanceSheetGroupingTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- References No definition available. + Details
Name: | us-gaap_FairValueDisclosuresAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration